Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Teva
Medtronic
Healthtrust
Daiichi Sankyo
Citi
Colorcon
Deloitte
Fish and Richardson

Generated: December 10, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DOXEPIN HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Doxepin Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00280839 Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation Completed Ortho-McNeil Neurologics, Inc. Phase 3 The purpose of this research study is to determine if topiramate is safe and effective in the treatment of smoking cessation
NCT00280839 Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation Completed University of Cincinnati Phase 3 The purpose of this research study is to determine if topiramate is safe and effective in the treatment of smoking cessation
NCT00280839 Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation Completed Lindner Center of HOPE Phase 3 The purpose of this research study is to determine if topiramate is safe and effective in the treatment of smoking cessation
NCT00465972 The Treatment of Insomnia in Patients With HIV Disease Completed Duke University Phase 4 This study is designed to evaluate the efficacy of two commonly prescribed sleep aids for use in patients who are HIV positive and suffer from insomnia.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Doxepin Hydrochloride

Condition Name

Condition Name for Doxepin Hydrochloride
Intervention Trials
Mucositis 2
Insomnia 2
Oral Complications of Radiation Therapy 1
Head and Neck Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Doxepin Hydrochloride
Intervention Trials
Mucositis 3
Sleep Initiation and Maintenance Disorders 3
Stomatitis 2
Small Cell Lung Carcinoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Doxepin Hydrochloride

Trials by Country

Trials by Country for Doxepin Hydrochloride
Location Trials
United States 49
Iran, Islamic Republic of 2
Switzerland 1
China 1
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Doxepin Hydrochloride
Location Trials
Minnesota 3
Illinois 2
Wisconsin 2
Ohio 2
North Carolina 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Doxepin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Doxepin Hydrochloride
Clinical Trial Phase Trials
Phase 4 2
Phase 3 4
Phase 2/Phase 3 1
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Doxepin Hydrochloride
Clinical Trial Phase Trials
Completed 9
Recruiting 3
Active, not recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Doxepin Hydrochloride

Sponsor Name

Sponsor Name for Doxepin Hydrochloride
Sponsor Trials
National Cancer Institute (NCI) 3
Alliance for Clinical Trials in Oncology 2
Isfahan University of Medical Sciences 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Doxepin Hydrochloride
Sponsor Trials
Other 18
NIH 3
Industry 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Covington
Harvard Business School
Fish and Richardson
Deloitte
Colorcon
Moodys
Healthtrust
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.